{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T16:52:32Z","timestamp":1794588752473,"version":"4.9.1"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7]]},"abstract":"<jats:p>The transgender community has faced a long-standing history of prejudice and discrimination that has negatively affected their health. A lack of health care provider education and comfort with transgender medicine further challenges the ability of this population to obtain competent, gender-affirming medical care. As with all patients, a thorough patient history with avoidance of assumptions of sexual orientation based on gender identity is integral to providing appropriate care for transgender individuals. Vaginal bleeding in transgender men should be evaluated in a similar manner to natal women, and with knowledge of the individual's present reproductive organs. The majority of transgender men receiving gender-affirming hormone therapy will have cessation of menses by 6 months of continuous use; thus, bleeding beyond this interval warrants measurement of hormone levels and further evaluation. Progesterone-only contraceptive methods including progesterone-only pills, medroxyprogesterone acetate, or a levonorgestrel intrauterine device can be used in transgender men and nonbinary patients with continued menses despite physiologic testosterone levels, or to act as a bridge method for menstrual cessation at the time of testosterone initiation. For bleeding refractory to progesterone methods, health care providers should discuss surgical options or the use of aromatase inhibitors with their patients. Counseling on fertility desires and family planning is integral to improving the reproductive care of transgender patients. Contraceptive counseling for transgender patients should include not only the efficacy and ease of use of available methods, but also discussion of advantages and disadvantages of contraceptive options with regard to the patient's gender identity.<\/jats:p>","DOI":"10.1097\/aog.0000000000003308","type":"journal-article","created":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T01:00:46Z","timestamp":1560301246000},"page":"81-90","source":"Crossref","is-referenced-by-count":38,"title":["Approaches to Vaginal Bleeding and Contraceptive Counseling in Transgender and Gender Nonbinary Patients"],"prefix":"10.1097","volume":"134","author":[{"given":"Amanda R.","family":"Schwartz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly A.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230711","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2105\/AJPH.2007.132035","article-title":"Health care utilization, barriers to care, and hormone usage among male-to-female transgender persons in New York City","volume":"99","author":"Sanchez","year":"2009","journal-title":"Am J Public Health"},{"key":"R4-20230711","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1210\/jc.2017-01658","article-title":"Endocrine treatment of gender-dysphoric\/gender-incongruent persons: an endocrine society clinical practice guideline","volume":"102","author":"Hembree","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"R5-20230711","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/15532739.2011.700873","article-title":"Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7","volume":"13","author":"Coleman","year":"2012","journal-title":"Int J Transgend"},{"key":"R8-20230711","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/hsw\/30.1.19","article-title":"Transgender health: findings from two needs assessment studies in Philadelphia","volume":"30","author":"Kenagy","year":"2005","journal-title":"Health Soc work"},{"key":"R9-20230711","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1089\/lgbt.2015.0124","article-title":"Differences in healthcare access, use, and experiences within a community sample of racially diverse lesbian, gay, bisexual, transgender, and questioning emerging adults","volume":"3","author":"Macapagal","year":"2016","journal-title":"LGBT Health"},{"key":"R10-20230711","first-page":"25","article-title":"Transgender health","volume":"86","author":"Feldman","year":"2003","journal-title":"Minn Med"},{"key":"R12-20230711","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s10508-017-1028-z","article-title":"Self-reported discrimination in health-care settings based on recognizability as transgender: a cross-sectional study among transgender U.S. citizens","volume":"47","author":"Rodriguez","year":"2018","journal-title":"Arch Sex Behav"},{"key":"R13-20230711","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1089\/jwh.2014.4918","article-title":"Care of the transgender patient: a survey of gynecologists' current knowledge and practice","volume":"24","author":"Unger","year":"2015","journal-title":"J Women's Health (Larchmt)"},{"key":"R16-20230711","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/AOG.0000000000000692","article-title":"Effects of cross-sex hormone treatment on transgender women and men","volume":"125","author":"Deutsch","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R17-20230711","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1507\/endocrj.EJ12-0319","article-title":"Dose-response analysis of testosterone replacement therapy in patients with female to male gender identity disorder","volume":"60","author":"Nakamura","year":"2013","journal-title":"Endocr J"},{"key":"R18-20230711","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/AOG.0b013e318262e320","article-title":"Diagnosis of abnormal uterine bleeding in reproductive-aged women. Practice Bulletin No. 128. American College of Obstetricians and Gynecologists","volume":"120","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R19-20230711","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijgo.2010.11.011","article-title":"FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age","volume":"113","author":"Munro","year":"2011","journal-title":"Int J Gynaecol Obstet"},{"key":"R20-20230711","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1111\/j.1743-6109.2012.02876.x","article-title":"Long-term evaluation of cross-sex hormone treatment in transsexual persons","volume":"9","author":"Wierckx","year":"2012","journal-title":"J Sex Med"},{"key":"R21-20230711","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1023\/A:1018638715498","article-title":"Endocrine therapy of transsexualism and potential complications of long-term treatment","volume":"27","author":"Futterweit","year":"1998","journal-title":"Arch Sex Behav"},{"key":"R22-20230711","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.ajog.2010.12.057","article-title":"Gynecologic malignancies in female-to-male transgender patients: the need of original gender surveillance","volume":"204","author":"Urban","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"R23-20230711","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.rbmo.2009.12.021","article-title":"Histology of genital tract and breast tissue after long-term testosterone administration in a female-to-male transsexual population","volume":"20","author":"Grynberg","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"R24-20230711","doi-asserted-by":"crossref","first-page":"257.e","DOI":"10.1016\/j.ajog.2018.12.021","article-title":"Uterine pathology in transmasculine persons on testosterone: a retrospective multicenter case series","volume":"220","author":"Grimstad","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"R25-20230711","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1111\/j.1743-6109.2009.01380.x","article-title":"Effect of long-term testosterone administration on the endometrium of female-to-male (FtM) transsexuals","volume":"6","author":"Perrone","year":"2009","journal-title":"J Sex Med"},{"key":"R26-20230711","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.tjog.2016.03.004","article-title":"Uterine and ovarian changes during testosterone administration in young female-to-male transsexuals","volume":"55","author":"Loverro","year":"2016","journal-title":"Taiwan J Obstet Gynecol"},{"key":"R28-20230711","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1080\/17441692.2015.1134613","article-title":"A global research synthesis of HIV and STI biobehavioural risks in female-to-male transgender adults","volume":"11","author":"Reisner","year":"2016","journal-title":"Glob Public Health"},{"key":"R29-20230711","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/epirev\/mxw003","article-title":"Cancer in transgender people: evidence and methodological considerations","volume":"39","author":"Braun","year":"2017","journal-title":"Epidemiol Rev"},{"key":"R30-20230711","doi-asserted-by":"crossref","first-page":"e0190172","DOI":"10.1371\/journal.pone.0190172","article-title":"Test performance and acceptability of self- versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients","volume":"13","author":"Reisner","year":"2018","journal-title":"PLoS One"},{"key":"R31-20230711","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/AOG.0000000000001866","article-title":"Feasibility of vaginal hysterectomy for female-to-male transgender men","volume":"129","author":"Obedin-Maliver","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R32-20230711","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1097\/AOG.0000000000002936","article-title":"Complication rates and outcomes after hysterectomy in transgender men","volume":"132","author":"Bretschneider","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R33-20230711","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1097\/AOG.0000000000002112","article-title":"Choosing the route of hysterectomy for benign disease. Committee Opinion No. 701. American College of Obstetricians and Gynecologists","volume":"129","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R34-20230711","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/AOG.0000000000001592","article-title":"Salpingo-oophorectomy at the time of benign hysterectomy: a systematic review","volume":"128","author":"Evans","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"suppl 2","key":"R35-20230711","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/humrep\/11.suppl_2.165","article-title":"A comparison of mechanisms underlying disturbances of bleeding caused by spontaneous dysfunctional uterine bleeding or hormonal contraception","volume":"11","author":"Fraser","year":"1996","journal-title":"Hum Reprod"},{"key":"R36-20230711","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S2213-8587(16)00036-X","article-title":"Testosterone therapy for transgender men","volume":"5","author":"Irwig","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R37-20230711","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1111\/j.1743-6109.2010.01912.x","article-title":"Effects of intramuscular testosterone undecanoate on body composition and bone mineral density in female-to-male transsexuals","volume":"7","author":"Mueller","year":"2010","journal-title":"J Sex Med"},{"key":"R38-20230711","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s00404-017-4295-y","article-title":"Effects of a hyperandrogenaemic state on the proliferation and decidualization potential in human endometrial stromal cells","volume":"295","author":"Freis","year":"2017","journal-title":"Arch Gynecol Obstet"},{"key":"R39-20230711","first-page":"e11","article-title":"Care for transgender adolescents. Committee Opinion No. 685. American College of Obstetricians and Gynecologists","volume":"129","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R40-20230711","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1200\/JCO.2002.20.3.751","article-title":"Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study","volume":"20","author":"Geisler","year":"2002","journal-title":"J Clin Oncol"},{"key":"R41-20230711","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13048-015-0131-9","article-title":"Use of aromatase inhibitors in practice of gynecology","volume":"8","author":"Usluogullari","year":"2015","journal-title":"J Ovarian Res"},{"key":"R42-20230711","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1530\/EJE-16-0526","article-title":"Long-term outcomes of letrozole treatment for precocious puberty in girls with McCune-Albright syndrome","volume":"175","author":"Estrada","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"R43-20230711","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0015-0282(02)03241-7","article-title":"A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women","volume":"78","author":"Fisher","year":"2002","journal-title":"Fertil Steril"},{"key":"R44-20230711","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(04)17666-6","article-title":"Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer","volume":"365","author":"Howell","year":"2005","journal-title":"Lancet"},{"key":"R45-20230711","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.contraception.2018.06.006","article-title":"Family planning and contraception use in transgender men","volume":"98","author":"Light","year":"2018","journal-title":"Contraception"},{"key":"R46-20230711","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jpag.2017.03.012","article-title":"The family planing needs of young transgender men","volume":"30","author":"Light","year":"2017","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R47-20230711","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/toxsci\/65.1.71","article-title":"Effects of prenatal testosterone propionate on the sexual development of male and female rats: a dose-response study","volume":"65","author":"Wolf","year":"2002","journal-title":"Toxicol Sci"},{"key":"R48-20230711","doi-asserted-by":"crossref","first-page":"867471","DOI":"10.1186\/1687-9856-2010-867471","article-title":"Prenatal virilization associated with paternal testosterone gel therapy","volume":"2010","author":"Patel","year":"2010","journal-title":"Int J Pediatr Endocrinol"},{"key":"R49-20230711","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jpag.2016.01.100","article-title":"Menstrual suppression and contraceptive choices in a transgender adolescent and young adult population","volume":"29","author":"Kanj","year":"2016","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R50-20230711","first-page":"62","article-title":"Selecting and monitoring hormonal contraceptives: an overview of available products","author":"Rice C","year":"2006","journal-title":"US Pharmacist"},{"key":"R51-20230711","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0010-7824(01)00302-X","article-title":"Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years","volume":"65","author":"Hidalgo","year":"2002","journal-title":"Contraception"},{"key":"R52-20230711","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/AOG.0000000000001047","article-title":"Emergency contraception. Practice Bulletin No. 152. American College of Obstetricians and Gynecologists","volume":"126","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R54-20230711","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.contraception.2012.09.006","article-title":"Treatment of bleeding irregularities in women with copper-containing IUDs: a systematic review","volume":"87","author":"Godfrey","year":"2013","journal-title":"Contraception"},{"key":"R55-20230711","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0002-9378(99)70120-1","article-title":"The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices","volume":"181","author":"Rivera","year":"1999","journal-title":"Am J Obstet Gynecol"},{"issue":"suppl 1","key":"R57-20230711","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/13625180801942754","article-title":"The contraceptive efficacy of Implanon: a review of clinical trials and marketing experience","volume":"13","author":"Graesslin","year":"2008","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"6 suppl","key":"R58-20230711","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.contraception.2007.01.020","article-title":"Copper-T intrauterine device and levonorgestrel intrauterine system: biological bases of their mechanism of action","volume":"75","author":"Ortiz","year":"2007","journal-title":"Contraception"},{"key":"R59-20230711","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.contraception.2015.01.007","article-title":"Risk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European active surveillance study on intrauterine devices","volume":"91","author":"Heinemann","year":"2015","journal-title":"Contraception"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006250-201907000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T19:13:21Z","timestamp":1689102801000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201907000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000003308","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]}}}